[go: up one dir, main page]

HK1041888A1 - 穩定低聚核苷酸及其用途 - Google Patents

穩定低聚核苷酸及其用途 Download PDF

Info

Publication number
HK1041888A1
HK1041888A1 HK02103552.2A HK02103552A HK1041888A1 HK 1041888 A1 HK1041888 A1 HK 1041888A1 HK 02103552 A HK02103552 A HK 02103552A HK 1041888 A1 HK1041888 A1 HK 1041888A1
Authority
HK
Hong Kong
Prior art keywords
oligonucleotide
oligonucleotide according
cys
asterisk
nucleotides
Prior art date
Application number
HK02103552.2A
Other languages
German (de)
English (en)
Inventor
Peymann Anischirwan
Uhlmann Eugen
Mag Matthias
Kretschmar Gerhardt
Helsberg Matthias
Winkler Irvin
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of HK1041888A1 publication Critical patent/HK1041888A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Dental Preparations (AREA)
HK02103552.2A 1993-11-12 1998-12-10 穩定低聚核苷酸及其用途 HK1041888A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4338704 1993-11-12
DE4338704A DE4338704A1 (de) 1993-11-12 1993-11-12 Stabilisierte Oligonucleotide und deren Verwendung

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK98113031.7A Addition HK1012000A (zh) 1993-11-12 1998-12-10 稳定低聚核苷酸及其用途

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK98113031.7A Division HK1012000A (zh) 1993-11-12 1998-12-10 稳定低聚核苷酸及其用途

Publications (1)

Publication Number Publication Date
HK1041888A1 true HK1041888A1 (zh) 2002-07-26

Family

ID=6502470

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103552.2A HK1041888A1 (zh) 1993-11-12 1998-12-10 穩定低聚核苷酸及其用途

Country Status (12)

Country Link
US (1) US6348312B1 (zh)
EP (2) EP1182206A3 (zh)
JP (1) JP3558230B2 (zh)
AT (1) ATE265465T1 (zh)
AU (1) AU696635B2 (zh)
CA (1) CA2135591C (zh)
DE (2) DE4338704A1 (zh)
DK (1) DK0653439T3 (zh)
ES (1) ES2218522T3 (zh)
HK (1) HK1041888A1 (zh)
NZ (1) NZ264894A (zh)
PT (1) PT653439E (zh)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4331670A1 (de) * 1993-09-17 1995-03-23 Hoechst Ag Neue Antisense-Oligonucleotide gegen HSV-1 sowie deren Herstellung
US20030026782A1 (en) * 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6776986B1 (en) 1996-06-06 2004-08-17 Novartis Ag Inhibition of HIV-1 replication by antisense RNA expression
US5821354A (en) * 1996-11-26 1998-10-13 Angiogene Inc. Radiolabeled DNA oligonucleotide and method of preparation
DE69808609T2 (de) * 1997-04-11 2003-06-12 G.D. Searle & Co., Chicago Antagonistische anti-avb3 integrin antikörper
WO1998050540A1 (en) * 1997-05-05 1998-11-12 Hoechst Marion Roussel Deutschland Gmbh MODIFIED ANTISENSE NUCLEOTIDES COMPLEMENTARY TO A SECTION OF THE HUMAN Ha-Ras GENE
EP0950709A1 (en) * 1998-04-17 1999-10-20 Hoechst Marion Roussel Deutschland GmbH Antisense oligonucleotides for the inhibition of integrin alphaV-subunit expression
US20030022854A1 (en) 1998-06-25 2003-01-30 Dow Steven W. Vaccines using nucleic acid-lipid complexes
US6693086B1 (en) * 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
EP0979869A1 (en) * 1998-08-07 2000-02-16 Hoechst Marion Roussel Deutschland GmbH Short oligonucleotides for the inhibition of VEGF expression
EP0978561A1 (en) * 1998-08-07 2000-02-09 Hoechst Marion Roussel Deutschland GmbH Antisense oligonucleotides for the inhibition of VEGF expression
DE19935303A1 (de) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonukleotide zur Inhibierung der Expression von humanem eg5
US6949520B1 (en) * 1999-09-27 2005-09-27 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
KR100917101B1 (ko) * 2000-08-04 2009-09-15 도요 보세키 가부시키가이샤 플렉시블 금속적층체 및 그 제조방법
AU2001297693A1 (en) * 2000-12-08 2002-09-12 Coley Pharmaceutical Gmbh Cpg-like nucleic acids and methods of use thereof
WO2002066092A2 (en) * 2001-02-23 2002-08-29 Angiogene Inc. Drug eluting device for treating vascular diseases
DE10159904A1 (de) * 2001-12-06 2003-07-03 Adnagen Ag Oligonukleotidanordnung, Verfahren zum Nukleotidnachweis sowie Vorrichtung hierfür
US9181551B2 (en) 2002-02-20 2015-11-10 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
US9657294B2 (en) 2002-02-20 2017-05-23 Sirna Therapeutics, Inc. RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
DE60310944T3 (de) 2002-08-05 2017-08-03 Silence Therapeutics Gmbh Weitere neue formen von interferierende rns moleküle
AR040996A1 (es) 2002-08-19 2005-04-27 Coley Pharm Group Inc Acidos nucleicos inmunoestimuladores
KR20110050745A (ko) * 2002-10-03 2011-05-16 탈자진 인코포레이티드 혈관항상성 유지제 및 그의 사용 방법
US20050282814A1 (en) * 2002-10-03 2005-12-22 Targegen, Inc. Vasculostatic agents and methods of use thereof
CA2502015A1 (en) * 2002-12-11 2004-06-24 Coley Pharmaceutical Group, Inc. 5' cpg nucleic acids and methods of use
US20040198640A1 (en) * 2003-04-02 2004-10-07 Dharmacon, Inc. Stabilized polynucleotides for use in RNA interference
US20050013812A1 (en) * 2003-07-14 2005-01-20 Dow Steven W. Vaccines using pattern recognition receptor-ligand:lipid complexes
EP1663316A2 (en) * 2003-09-25 2006-06-07 Coley Pharmaceutical Group, Inc. Nucleic acid lipophilic conjugates
WO2005078094A2 (en) * 2004-02-06 2005-08-25 Dharmacon, Inc. Stabilized rnas as transfection controls and silencing reagents
US20090280567A1 (en) * 2004-02-06 2009-11-12 Dharmacon, Inc. Stabilized sirnas as transfection controls and silencing reagents
TWI235440B (en) * 2004-03-31 2005-07-01 Advanced Semiconductor Eng Method for making leadless semiconductor package
KR101147147B1 (ko) * 2004-04-01 2012-05-25 머크 샤프 앤드 돔 코포레이션 Ｒｎａ 간섭의 오프 타겟 효과 감소를 위한 변형된폴리뉴클레오타이드
EP1809614B1 (en) 2004-04-08 2014-05-07 TargeGen, Inc. Benzotriazine inhibitors of kinases
US7652051B2 (en) 2004-08-25 2010-01-26 Targegen, Inc. Heterocyclic compounds and methods of use
MY159370A (en) * 2004-10-20 2016-12-30 Coley Pharm Group Inc Semi-soft-class immunostimulatory oligonucleotides
US7923207B2 (en) 2004-11-22 2011-04-12 Dharmacon, Inc. Apparatus and system having dry gene silencing pools
US7923206B2 (en) * 2004-11-22 2011-04-12 Dharmacon, Inc. Method of determining a cellular response to a biological agent
US7935811B2 (en) * 2004-11-22 2011-05-03 Dharmacon, Inc. Apparatus and system having dry gene silencing compositions
JP2008531018A (ja) * 2005-02-24 2008-08-14 コーリー ファーマシューティカル グループ，インコーポレイテッド 免疫刺激性オリゴヌクレオチド
US20060223777A1 (en) * 2005-03-29 2006-10-05 Dharmacon, Inc. Highly functional short hairpin RNA
CA2611720A1 (en) * 2005-06-08 2006-12-14 Targegen, Inc. Methods and compositions for the treatment of ocular disorders
BR122021011788B1 (pt) * 2005-11-01 2022-01-25 Impact Biomedicines, Inc Inibidores de biaril meta pirimidina de cinases, composição farmacêutica e processo para preparar uma composição farmacêutica
US8604042B2 (en) * 2005-11-01 2013-12-10 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases
US8133900B2 (en) * 2005-11-01 2012-03-13 Targegen, Inc. Use of bi-aryl meta-pyrimidine inhibitors of kinases
EP1991678B2 (en) * 2006-02-15 2020-07-15 Rechtsanwalt Thomas Beck Compositions and methods for oligonucleotide formulations
US7691858B2 (en) * 2006-04-25 2010-04-06 Targegen, Inc. Kinase inhibitors and methods of use thereof
US8252755B2 (en) * 2006-09-22 2012-08-28 Dharmacon, Inc. Duplex oligonucleotide complexes and methods for gene silencing by RNA interference
NZ575437A (en) 2006-09-27 2012-02-24 Coley Pharm Gmbh Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
CN101874111B (zh) 2007-11-28 2013-06-05 国立大学法人东京医科齿科大学 利用内源性乳糜微粒递送用于抑制靶基因表达的核酸的体系
US8188060B2 (en) 2008-02-11 2012-05-29 Dharmacon, Inc. Duplex oligonucleotides with enhanced functionality in gene regulation
US20130267576A1 (en) * 2010-07-16 2013-10-10 Napajen Pharma, Inc. (nucleic acid)-polysaccharide complex
WO2012027206A1 (en) 2010-08-24 2012-03-01 Merck Sharp & Dohme Corp. SINGLE-STRANDED RNAi AGENTS CONTAINING AN INTERNAL, NON-NUCLEIC ACID SPACER
ES2663009T3 (es) 2010-10-29 2018-04-10 Sirna Therapeutics, Inc. Inhibición de la expresión génica mediada por interferencia por ARN utilizando ácidos nucleicos de interferencia cortos (ANic)
AU2010363329A1 (en) 2010-11-07 2013-05-09 Targegen, Inc. Compositions and methods for treating myelofibrosis
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
EP2781523A1 (en) 2013-03-18 2014-09-24 Miltenyi Biotec GmbH Lipophilic oligonucleotide analogs
CN110997933B (zh) * 2017-08-02 2024-01-09 萨斯特德特股份有限两合公司 用于稳定无细胞核酸和细胞的方法和组合物

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
US5110802A (en) * 1987-07-14 1992-05-05 City Of Hope Oligonucleotide phosphonates and method of inhibiting a human immunodeficiency virus in vitro utilizing said oligonucleotide phosphonates
JPH04501052A (ja) * 1988-02-26 1992-02-27 ザ・ウスター・フアウンデーシヨン・フオー・バイオメデイカル・リサーチ 外来性オリゴヌクレオチドによるｈｔｌｖ―３の抑制
CA2029273A1 (en) * 1989-12-04 1991-06-05 Christine L. Brakel Modified nucleotide compounds
EP0544716B1 (en) * 1990-08-14 2002-12-18 Isis Pharmaceuticals, Inc. Oligonucleotide modulation of cell adhesion
JPH04154794A (ja) * 1990-10-15 1992-05-27 Yodogawa Seiyaku Kk アンチセンスオリゴデオキシリボヌクレオチドおよびそれを有効成分とするｈｉｖ活性阻害剤
EP0588881A1 (en) * 1991-05-10 1994-03-30 HYBRIDON, Inc. 3'-end blocked oligonucleotides
WO1992020348A1 (en) * 1991-05-23 1992-11-26 Temple University - Of The Commonwealth System Of Higher Education Treatment of colorectal carcinoma with antisense oligonucleotides to c-myb proto-oncogene
AU659482B2 (en) * 1991-06-28 1995-05-18 Massachusetts Institute Of Technology Localized oligonucleotide therapy
KR930016437A (ko) 1992-01-22 1993-08-26 귀틀라인, 슈미트 올리고뉴클레오티드 유사체, 이의 제조방법 및 용도
AU3596593A (en) * 1992-02-19 1993-09-13 Baylor College Of Medicine Oligonucleotide modulation of cell growth
AU678980B2 (en) * 1992-07-02 1997-06-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Method of inhibiting viral replication
ATE162198T1 (de) * 1992-07-27 1998-01-15 Hybridon Inc Oligonukleotid alkylphosphonothiate
US5821234A (en) * 1992-09-10 1998-10-13 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of proliferation of vascular smooth muscle cell
DE4321946A1 (de) * 1993-07-01 1995-01-12 Hoechst Ag Methylphosphonsäureester, Verfahren zu deren Herstellung und deren Verwendung
JP2000203104A (ja) * 1999-01-14 2000-07-25 Minolta Co Ltd プリンタ及びプリンタ制御装置
US7821415B1 (en) * 2008-04-04 2010-10-26 Kimberlin Denver K Pneumatically operated patient bed monitor

Also Published As

Publication number Publication date
DE4338704A1 (de) 1995-05-18
EP1182206A3 (de) 2002-08-21
JPH07194385A (ja) 1995-08-01
CA2135591A1 (en) 1995-05-13
EP0653439B1 (de) 2004-04-28
DK0653439T3 (da) 2004-08-09
AU696635B2 (en) 1998-09-17
AU7779994A (en) 1995-05-18
DE59410371D1 (de) 2004-06-03
EP0653439A3 (de) 1995-10-25
JP3558230B2 (ja) 2004-08-25
NZ264894A (en) 1997-07-27
EP0653439A2 (de) 1995-05-17
US6348312B1 (en) 2002-02-19
ATE265465T1 (de) 2004-05-15
PT653439E (pt) 2004-09-30
ES2218522T3 (es) 2004-11-16
EP1182206A2 (de) 2002-02-27
CA2135591C (en) 2010-10-26

Similar Documents

Publication Publication Date Title
HK1041888A1 (zh) 穩定低聚核苷酸及其用途
CA2168409C (en) G cap-stabilized oligonucleotides
EP0677056B1 (en) Oligonucleotide alkylphosphonates and alkylphosphonothioates
US6600032B1 (en) 2′-O-aminoethyloxyethyl-modified oligonucleotides
TEMSAMANI et al. Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs
AU678769B2 (en) Oligonucleotide alkylphosphonothioates
EP0736093B1 (en) ANTISENSE NUCLEIC ACIDS FOR THE PREVENTION AND TREATMENT OF DISORDERS IN WHICH EXPRESSION OF c-erbB-2 PLAYS A ROLL
US20030083477A1 (en) Three component chimeric antisense oligonucleotides
WO1992000990A1 (en) Interleukin receptor expression inhibiting antisense oligonucleotides
KR20020033744A (ko) 사람 ｅｇ5의 발현을 억제하는 올리고뉴클레오티드
US5563050A (en) Antisense oligonucleotides against HSV 1, and their preparation
EP0975654A1 (en) Composition and method for treatment of cmv infections
JP2003505517A (ja) 接合体ならびにそれらの製造方法および生体膜を横切り分子を輸送するためのそれらの使用
HK1012000A (zh) 稳定低聚核苷酸及其用途
HK1012005B (zh) G-cap稳定低聚核苷酸
US6673912B1 (en) 2′-O-aminoethyloxyethyl-modified oligonucleotides
EP4332221A1 (en) Threose nucleic acid antisense oligonucleotides and methods thereof
Usman et al. Nucleozymes